LLY
Eli Lilly and Company
- Net income, 2025
- $20.6B
- YoY, 2025
- +94.9%
- 5-year CAGR
- +27.2%
- 10-year CAGR
- +24.0%
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | $20.6B | +94.9% |
| 2024 | $10.6B | +102.1% |
| 2023 | $5.2B | −16.1% |
| 2022 | $6.2B | +11.9% |
| 2021 | $5.6B | −9.9% |
| 2020 | $6.2B | −25.5% |
| 2019 | $8.3B | +157.4% |
| 2018 | $3.2B | — |
| 2017 | −$204M | — |
| 2016 | $2.7B | +13.7% |
| 2015 | $2.4B | +0.7% |
| 2014 | $2.4B | −49.0% |
| 2013 | $4.7B | +14.6% |
| 2012 | $4.1B | −6.0% |
| 2011 | $4.3B | −14.2% |
| 2010 | $5.1B | +17.1% |
| 2009 | $4.3B | — |
| 2008 | −$2.1B | — |
| 2007 | $3.0B | — |